Expert Reviews: 5 Ways Trump’s FDA May Skip Drug Trials
Under Trump, the FDA is seeking to abandon traditional expert reviews for new drugs. Find out how this major policy shift could impact public health and safety.
clinical trials
Read More
CRO’s Services: PhaseV Adds 1 New AI Optimization Tool
PhaseV’s new trial optimization software is now available, enhancing CRO’s services with AI-powered analytics to improve clinical trial success and efficiency.
Gout Drug from Atom Shows Phase 3 Win Over Rivals
Atom’s new gout drug shows promising Phase 3 trial results, suggesting it could be a superior treatment option and effectively challenge current market leaders.